1 / 12

Homeostatic Model Assessment—HOMA

Homeostatic Model Assessment—HOMA. Understanding A Complex Evaluation of Glucose Control Melanie Aganon, PharmD Candidate University of Florida College of Pharmacy. Homeostatic Model Assessment. Assesses beta-cell function (%B) and insulin resistance (%S)

mayo
Download Presentation

Homeostatic Model Assessment—HOMA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Homeostatic Model Assessment—HOMA Understanding A Complex Evaluation of Glucose Control Melanie Aganon, PharmD Candidate University of Florida College of Pharmacy

  2. Homeostatic Model Assessment • Assesses beta-cell function (%B) and insulin resistance (%S) • Described in percentages, with 100% as the median normal value • Uses fasting plasma glucose (FPG) and fasting plasma insulin (FPI) to determine %B and %S • 2 types of HOMA • HOMA1 – original model • HOMA2 – updated computer model Wallace TM, Levy JC, and Matthews DR. Use and Abuse of HOMA Modelin. Diabetes Care 27: 1487-1495, 2004. Wallace TM and Matthews DR. The assessment of insulin resistance in man. Diabetic medicine, 19, 527-534.

  3. HOMA 1 – the original • Based on equations from Matthews et al. IR =insulin resistance (%S) %B=beta-cell function Wallace TM, Levy JC, and Matthews DR. Use and Abuse of HOMA Modelin. Diabetes Care 27: 1487-1495, 2004. Matthews DR, Hosker JP, Rudenski AS, naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and Insulin concentrations in man. Diabetologia 28:412-419, 1985.

  4. HOMA 1 – the original As insulin sensitivity decreases, insulin production goes up to compensate then decreasing beta cell function leads to diabetes and eventually insulin dependence. HOMA measures this Wallace TM, Levy JC, and Matthews DR. Use and Abuse of HOMA Modelin. Diabetes Care 27: 1487-1495, 2004. Matthews DR, Hosker JP, Rudenski AS, naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and Insulin concentrations in man. Diabetologia 28:412-419, 1985.

  5. HOMA2 – the computer model • Updated in 1996 to account for: • Variations in hepatic and peripheral glucose resistance • Reduction in the suppression of hepatic glucose output • Reduction of peripheral glucose-stimulated glucose reuptake Wallace TM, Levy JC, and Matthews DR. Use and Abuse of HOMA Modelin. Diabetes Care 27: 1487-1495, 2004.

  6. Additional Computations • Can determine insulin sensitivity (%S) and beta-cell function (%B) from: • Fasting plasma glucose and RIA insulin • Specific insulin • C-peptide concentrations if • Insulin concentration is in range of 1 - 2,200pmol/L • Glucose concentration is in range of 1 – 25 mmol/L Wallace TM, Levy JC, and Matthews DR. Use and Abuse of HOMA Modelin. Diabetes Care 27: 1487-1495, 2004.

  7. HOMA2 – the computer model Computer modeling allows for smoother curves and better predictions Wallace TM, Levy JC, and Matthews DR. Use and Abuse of HOMA Modelin. Diabetes Care 27: 1487-1495, 2004.

  8. HOMA2 – the computer model Can be downloaded from this site: http://www.dtu.ox.ac.uk/homacalculator/download.php Diabetes Trials Unit: The Oxford Centre of Diabetes, Endocrinology, and Metabolism website. Accessed Octber 29, 2010. Available at <http://www.dtu.ox.ac.uk/homacalculator/download.php>.

  9. Sampling for HOMA • Insulin secretion is pulsate • Recommended to take 3 samples in 5-minute intervals • Use the average • Single sample coefficients of variation • HOMA-%S: 10.3% • HOMA-%B: 7.7% Wallace TM, Levy JC, and Matthews DR. Use and Abuse of HOMA Modelin. Diabetes Care 27: 1487-1495, 2004.

  10. Use in Individuals • Track changes in insulin sensitivity and beta-cell function • Determine if either insulin sensitivity or beta-cell failure dominates (this is used in determining Medicare coverage of insulin pumps • Uses triplicate insulin samples to avoid temporary beta-cell exhaustion Wallace TM, Levy JC, and Matthews DR. Use and Abuse of HOMA Modelin. Diabetes Care 27: 1487-1495, 2004.

  11. Points to remember • Difficult to use in patients using insulin • Exogenous insulin does not undergo the same first-metabolism as endogenous metabolism • Need to take samples when glucose and insulin concentrations are in steady state • Patients on secretagogues • Interpret results with caution • Improvement in beta-cell function reflects secretagogue mechanism of action in first year • Will show a decline thereafter • Cannot use in animal studies Wallace TM, Levy JC, and Matthews DR. Use and Abuse of HOMA Modelin. Diabetes Care 27: 1487-1495, 2004.

  12. References • Diabetes Trials Unit: The Oxford Centre of Diabetes, Endocrinology, and Metabolism website. Accessed Octber 29, 2010. Available at <http://www.dtu.ox.ac.uk/homacalculator/download.php>. • Lu Chuanyi M, Nicoll Diana, McPhee Stephen J, Pignone Michael, "Common Laboratory Tests" (Chapter). Diana Nicoll, Stephen J. McPhee, Michael Pignone: Pocket Guide • to Diagnostic Tests, 5e: http://www.accesspharmacy.com.lp.hscl.ufl.edu/content.aspx?aID=3135000. • Matthews DR, Hosker JP, Rudenski AS, naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985. • Wallace TM, Levy JC, and Matthews DR. Use and Abuse of HOMA Modelin. Diabetes Care 27: 1487-1495, 2004. • Wallace TM and Matthews DR. The assessment of insulin resistance in man. Diabetic medicine, 19, 527-534.

More Related